SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " agnos " 1,005 found 🔀 AI-powered Shuffle
Jeremy Clarkson in remission from prostate cancer
The 66-year-old announced the positive news days after he shared his "aggressive" cancer diagnosis.
Success via SNF mental health assistants: How one provider slashed antipsychotics use, bad behavior and hospitalizations
One of the nation’s largest nursing homes is expanding its behavioral health initiatives, offering important insights for caregiving as providers nationwide admit more patients than ever with serious mental illness or other complex diagnoses.
Breakthrough Science Meets Market Skepticism: Insight Molecular Diagnostics Inc. (IMDX)’s Defining Moment
Insight Molecular Diagnostics Inc. (NASDAQ:IMDX) is one of the high-growth micro-cap stocks to buy now. On June 11, Insight Molecular Diagnostics Inc. (NASDAQ:IMDX) announced the online publication in the American Journal of Transplantation of new data demonstrating the statistical superiority of its flagship GraftAssure transplant rejection monitoring assay. The study showed that the novel GraftAssure […]
A brain-computer interface has, for the first time, restored fluent everyday speech to a person who had lost it — a man with ALS who had not spoken aloud in years until a small implant from the BrainGate clinical trial began translating his attempts to speak directly into computer-synthesised words, in a result researchers reported in June 2026
Casey Harrell can now talk for twelve hours at a stretch. Two years ago, he could not talk at all. The ALS he was diagnosed with several years earlier had progressively destroyed the motor neurons controlling the muscles of his face and throat, leaving him with the symptoms doctors call dysarthria and, eventually, anarthria — […]
The Healthcare Leaders Shaping Tomorrow – and the Challenges Facing Them
Healthcare innovation is advancing at a pace few could have imagined decades ago, from gene-editing therapies and lifesaving vaccines to artificial intelligence systems that could transform how doctors diagnose and treat disease. But at a time of unprecedented scientific progress, industry leaders ...
Focus on Prevention to Solve the Pediatric Mental Health Crisis
Pediatric mental health facilities are chronically understaffed and underfunded, so focusing on prevention is critical to solving the mental health crisis. And that means targeting technological advances, better mental health education and early diagnosis, industry leaders say. As part of the U.S.
One in Three Middle-Aged Adults Struggle With Basic, ‘Everyday’ Health Tasks
One in three middle-aged American adults ages 35 to 64 cannot consistently read prescription instructions correctly, understand medical forms or recall details from doctor visits involving chronic condition diagnoses, according to a recent study.
Corey Feldman Reveals 'Misdiagnosis' After Medical Emergency on Flight, Says He Actually Had Food Poisoning
The actor reassured fans two days after he was met by paramedics at LAX after falling ill on a flight
Corey Feldman breaks silence, reveals medical 'misdiagnosis'
Corey Feldman is speaking out and clarifying his medical emergency.
'Top Gear' star Jeremy Clarkson reveals 'aggressive' cancer diagnosis after health scares
Jeremy Clarkson reveals he is battling aggressive but early-stage prostate cancer in the final two episodes of "Clarkson's Farm" season five.
Allegheny Health Network helps cancer patients know they're not alone
When you hear you're diagnosed with cancer, it can be overwhelming. It can leave questions, anger and a feeling of seclusion.
Lil Nas X shares mental health update
Lil Nas X tells fans he's "doing better and creating freely" after his 2025 arrest and bipolar diagnosis.
How surviving leukemia changed Duke Health CEO's approach to patient care
A life-threatening leukemia diagnosis forced Dr. David Zaas to experience healthcare from the other side of the hospital bed. Now, the new Duke University Health System CEO says those lessons are guiding his approach to patient care and the future of Duke Health.
Jeremy Clarkson, ex-’Top Gear’ host, says he has ‘aggressive’ cancer
(CNN) — Jeremy Clarkson has announced that he has been diagnosed with an “aggressive” form of cancer.
Jeremy Clarkson reveals ‘aggressive’ prostate cancer diagnosis during ‘Clarkson’s Farm’ episode
The British television presenter said the disease had been found early.
Early-Onset Cancers Are On The Rise. Knowing Your Family History Is Crucial.
By Cara Anthony and Blake Farmer - Nashville Public Radio and KFF Health News HealthDay ReportersWEDNESDAY, June 17, 2026 (HealthDay News) — Bryce Ramsey of Madison, Mississippi, was 33 when she was diagnosed with colorectal cancer. Upon noticing blood in her stool, she blamed the hemorrhoids she’d developed after delivering her son eight years earlier. Ramsey didn’t initially link her symptoms ...
Mental Health Can Complicate Family Planning
Five stories show the hurdles that people with psychological diagnoses face when considering parenthood.
Corey Feldman diagnosed with 'really bad case of food poisoning,' released from hospital after mid-flight medical emergency
'Stand by Me' actor Corey Feldman has been released from the hospital following a mid-flight medical emergency on a flight to Los Angeles.
Corey Feldman shares health update, diagnosis after hospitalization
Corey Feldman received a diagnosis after spending the night at a hospital due to a medical emergency he'd experienced on a flight.
Adaptive plots splitting Pfizer-partnered drug discovery unit from diagnostics business
Adaptive Biotechnologies is planning to separate its drug discovery and diagnostics businesses,
Lance Bass on Having Type 1.5 Diabetes, Being Misdiagnosed, and Taking Control of His Health
In a new interview with Health, the former NSYNC singer opens up about the frustration of incorrectly treating type 2 diabetes for years and how he's currently managing his true diagnosis.
Radiology Partners affiliate inks in-network deal with Anthem Blue Cross
The deal is with Golden State Imaging Associates, which serves Southern California, providing 24/7 diagnostic and interventional services to hospitals and other referrers.
Amid confusion over Pfizer's emergency penicillin program, newborn is diagnosed with preventable syphilis
Congenital syphilis should be preventable. An Arizona case shows how drug shortages and procedural hurdles are fueling a growing public health crisis.
From PCOS to PMOS: New name reflects women’s metabolic health
Global multidisciplinary health professionals and organizations have updated the name polycystic ovary syndrome (PCOS) to polyendocrine metabolic ovarian syndrome (PMOS), arguing that the former is “inaccurate.” They critique that the old name implied greater focus on pathological ovarian cysts, contributing to slower diagnosis, stigma, and limited research and policy framing for the 170 million women living with the condition.
UK hypermobility sufferers wait up to 21 years for diagnosis, study suggests
Awareness of disorders such as hypermobile Ehlers-Danlos syndrome is low among British healthcare professionals
Health officials warn of possible measles exposure at SFO, San Jose locations
Santa Clara County health officials are urging the public to monitor for symptoms after a resident diagnosed with measles traveled through SFO and visited two San Jose businesses while contagious.
Health officials warn of possible measles exposure at SFO, San Jose locations
Santa Clara County health officials are urging the public to monitor for symptoms after a resident diagnosed with measles traveled through SFO and visited two San Jose businesses while infectious.
ABC New York's Bill Ritter reveals Alzheimer's diagnosis on air, steps down from anchoring: ‘My life has taken a turn’
Bill Ritter announced he was stepping down from anchoring duties for ABC New York and revealed on air that he has been diagnosed with Alzheimer's: 'My life has taken a turn.'
Shohei Ohtani leaves game with injury, Dodgers announce initial diagnosis
Los Angeles Dodgers star Shohei Ohtani was well on his way to a third consecutive National League MVP award on June 11 when he left a game against the Pittsburgh Pirates with an injury. Ohtani left the game with left…
One in three middle-aged adults struggle with basic, ‘everyday’ health tasks
Patients had trouble reading prescription instructions, recalling details about new diagnoses
CALL UP: How Utah’s Psychiatric Consultation Program Expands Access to Mental Health Care
Utah’s CALL-UP psychiatric consultation program connects providers to mental health specialists, improving access, diagnosis, and treatment statewide.
The science of seeing inside explosions
During the Manhattan Project, Los Alamos scientists needed a diagnostic tool. Like an x-ray confirming a broken leg bone, the researchers wanted to be able to see into the smoke cloud of detonation products. They needed to verify that the implosion remained symmetric to ensure an efficient detonation. Although it was a time when scientific breakthroughs came quickly, this challenge stumped them, and their initial efforts to use x-rays to visualize the event were limited.
Why AI Is Creating New Cybersecurity Risks For Healthcare
AI is helping hospitals improve diagnostics and patient care, but it's also giving cybercriminals new tools to target healthcare systems.
Doctors Should Do More Screening for Excess Body Fat and Its Health Risks
Nearly 90% of Americans meet the criteria for CKM syndrome. New guidelines have been issued for diagnosing and treating the disorder.
UToledo Health Now Offering FDA-Approved Infusion Therapy to Help Slow Early Alzheimer’s Progression
Kisunla targets amyloid plaques associated with Alzheimer's disease and is available to eligible patients with early symptomatic diagnoses.
Star Trek star's family awarded $13M in heart failure malpractice case
Nichelle Nichols, who played Lt. Uhura in Star Trek, died from undiagnosed and untreated heart failure after seeking medical treatment.
We can create the future of science right now
Paul Litvak is the founder and Executive Director of the Robyn Dawes Institute and a Visiting Scholar at UC Berkeley. He has a PhD in Behavioral Decision Research from Carnegie Mellon where he studied emotions and the sunk cost bias. Over 15 years in industry, he solved a wide range of challenging technical problems. At Meta he created models optimizing the ad review process. At Google he ran experiments to measure social influence. At Airbnb, he was a product manager leading machine learning teams optimizing search ranking and price suggestions. He also co-founded and led product at Rhythmic Health, a venture-backed biosensing startup, creating an accurate low cost system using a color changing strip and a smart phone to measure salivary lactate. The bottleneck At this point, it is uncontroversial to say that science needs to stop using the PDF article as the unit of knowledge and currency. The unbearable slowness of scientific publishing, the profit motive and margins: I’m not saying anything new. The PDF also sucks because it’s hard to extract structured information, which makes it hard to do evidence synthesis. As a result, we do much less evidence synthesis than is needed. And evidence synthesis ultimately undergirds most policy and medical decision-making. I can see second-by-second real-time odds for any sporting or newsworthy event, but a school board can’t see the best evidence on whether their 8th graders should be taught algebra. As a society, we don’t treat this as an important problem. Again, not controversial. Not only is the problem well understood, but the solution has already been laid out. What we need is AI-assisted living evidence synthesis - (1) an open knowledge graph of atomic claims, (2) claims linked to evidence, (3) assessment and synthesis of each piece of evidence, and (4) continuous updating with new data. What few realize (yet) is that the technical capacity to build this vision for a significant portion of science already exists. Not only that, scientists and startup teams are already building many of these components. I know this because I’ve been surveying the space and talking to many of the builders. There are some missing pieces: for example, evaluations of how well some of the components work. But at this point, most of what’s missing is a fully end-to-end working integration of all of these parts. In the rest of this essay, I’m going to lay out all the parts of a working living evidence layer for science and who is working on them, and propose concrete next steps for building this system. What’s now possible The diagram above outlines the components of a living evidence synthesis platform, including some of the teams working on each component1. Scientific PDFs are processed into claims with associated evidence. The evidence is subjected to a forensic audit, methodological evaluation and robustness and reproducibility checks. Finally it’s given a weight in a continuously updating synthesis. What follows is a description and status of each component and a few of the teams working on them. Document understanding The first thing you need to be able to do is turn an article into structured data. Mostly that means parsing PDFs. There are often multicolumn layouts that confuse non-specialized PDF to text processing libraries. For scientific papers, there is the added complexity of parsing formulas and tables and figures. This is a really hot area - there are startups offering APIs, and it seems like a new open source package gets posted to Github every few weeks. What follows isn’t exhaustive. A package called GROBID was the state of the art for a while, they didn’t update their package for nearly two years until very recently. In the meantime reducto.ai released an AI powered PDF extraction API, PaddleOCR became popular, IBM released a model called Docling, and both Mistral and Gemini created models and libraries. I also know of at least one other well-funded psychology research group working on a paper parser. By contrast, there are few open evals in this space, with no extensive evals for complex table comprehension in particular. Nonetheless, I’m confident this will be a solved problem soon, given the combination of LLM advances and developer interest. Hypothesis level extraction There has been increasing interest in comprehending the extracted text of papers and linking information to evidence for each hypothesis. A lot of work has already been done. Trialstreamer (Marshall et al. 2020) and RobotReviewer LIVE (Marshall et al. 2023) demonstrated automated extraction of trial population, intervention, and outcome at scale on clinical RCTs. PaperQA2 (Skarlinski et al. 2024) and Ai2 ScholarQA (2024) extended this to retrieval-augmented question answering with citation grounding. Elicit, Consensus, and SciSpace operationalized claim-level extraction for end users. OpenEval (Booeshaghi et al. 2026) is the most recent and most ambitious: 1.96 million atomic claims extracted from 16,087 eLife manuscripts using Claude Sonnet 4.5, grouped into ~299,000 results, with LLM evaluations showing 81% agreement with human peer review on a 2,487-paper subset. None of these solutions link claims to test-statistics, as you would need to evaluate randomized controlled trials. This is why I built the evidence.guide API - to extract hypotheses and associated test statistics from behavioral science papers. The best public eval of this kind of extraction I’m aware of comes from the recent SCORE project - they had humans code thousands of psychology papers to extract their claims by hand. It would be extremely helpful to the world if all scientific PDFs were available as structured open data. I’ve been working to make this happen, both directly at Berkeley and through coordination with large entities I can’t yet speak of; as hard as it is to do, I think it’s possible2. Forensic audit A lot of work has been done on forensic audit, but some gaps remain. Of course, for biology papers that rely on images for evidence, there are a variety of tools (notably Proofig and ImageTwin) to spot anomalies. These are still well short of what sleuths like Elizabeth Bik can do on her own, but these tools are constant companions among fraud analysts. There’s someone working on auditing Excel files for anomalies, and a number of teams are automating numerical checks like GRIM and SPRITE, including Scrutiny project, the INSPECT-SR team as well as statcheck. The regcheck team is building a way to use AI to compare preregistrations to analyses in papers, to ensure there aren’t significant deviations. Nonetheless, there are many other kinds of anomalies to screen for, both public and less publicly known. And there are no formal evals for anomaly detection that I’m aware of. Still, there’s a lot to draw from in this space and I’m pretty certain we will be able to scan papers for most kinds of obvious anomalies in the near future. Methodological review This area has been white hot, though I fear for many of the startups in this space, because this capability may become commoditized. There are at least six different AI peer review companies, including Refine.ink, Reviewer3, ReviewerZero.ai, Q.E.D. Science, Paper Wizard, and Isitcredible. Coarse (a pun on refine) was also recently created as an open source alternative. These systems provide qualitative feedback on the content of papers, spotting methodological weaknesses and mathematical errors. They seem to work pretty well, and many academics report bitterly that they exceed the average quality of typical peer reviewers. But there are few evals here either. What evals exist so far involve using LLM-as-judge (circularity problems abound) or comparing against human reviews of questionable quality. What you’d ideally want is an eval that measures capturing known errors in papers3. Reproducibility and robustness Another active area has been using AI agents to automate computational reproducibility4 and robustness5 checks in papers that report numerical results. For more recent papers where data and code are available, AI agents can see whether they can re-run the analyses and produce the numbers reported in the published paper. In addition to a handful of individual academics who have been experimenting using Claude Code for this, the Institute for Replication is a leading group working on building an end to end system. The evals related to this problem are the most mature, with CORE-Bench (Siegel, Kapoor, Narayanan 2024) and PaperBench (OpenAI 2025) available to benchmark agents on this task. There is also work on getting AI agents to test alternative ways of analyzing the data to ensure the results are robust to small analytic design choices. Synthesis This is the most underdeveloped area where significant investment is required. Although some automated evidence synthesis systems exist — for example, otto-sr is building an AI agent to write systematic reviews — none of these incorporate the full range of paper level signals to weight evidence appropriately. Nor is there anything like an eval or a gold standard for a good systematic review. Arguably Cochrane reviews are the closest we have to gold standard human systematic reviews, though I’ve heard academics in the know complain about their uneven quality. A key question for a synthesis platform is how to weight anomalies and methodological issues in assessing the quality of a piece of evidence. This is an unsolved problem and one I’m very keen to work on. Continuous updating There are many pieces of basic infrastructure available for monitoring for new research and initiating updates. OpenAlex is the current open citation graph. Retraction Watch integrated into Crossref in October 2023. Scite tracks how citations support, contrast, or mention prior claims. The Living Evidence Network demonstrated continuous-update workflows in clinical guidelines. Engineering this is a relatively straightforward task. When you look over this technical architecture and all the progress being made, it’s hard not to be optimistic that a living guide to scientific evidence will be built. The stakeholders are ready The social infrastructure for this is starting to coalesce — it’s not just a pie in the sky academic exercise to imagine this coming into existence. Institutions like the Center for Open Science, the Institute for Replication, the INSPECT-SR, the Living Evidence Network and more are all working on scaling work to improve research quality. Funders are also aligned. The Sloan Foundation has funded living evidence work through COS. Coefficient Giving supports the Institute for Replication and COS. The Astera Institute and the Institute for Progress have shown interest in this space. NIH has established an Office for Replication and Reproducibility. Although there are (very unfortunately) serious headwinds in science funding generally, there is an active group of funders interested in metascience. A brief word about what I’ve been doing at RDI. First, as a Visiting Scholar at Berkeley I’ve been actively figuring out how a non-profit and a public university can conduct and make public the results of large-scale academic article data mining. With some of the money I raised from donors, I commissioned a legal analysis of recent case law and publisher text data mining (TDM) agreements in order to understand whether a massive open data mining of academic articles is possible (with caveats, it is). I’ve also been working to bring together stakeholders in this space, and identify gaps. I’ve also been doing some software development in this space, with more to come. A pilot proposal The assumption undergirding all of this is that an AI, given all this information, would make the right judgment about a scientific claim with lots of conflicting evidence, weighing all the factors appropriately. That’s the hypothesis we need to test. Randomized control trial research is the best place to focus on first. RCTs are used to make many of the important decisions in society - from medical trials to public policy changes. And they use a relatively uniform set of inferential statistics with lots of known and available diagnostics. Behavioral science experiments, within the broader realm of RCTs, should be first used as a testbed whose results can be generalized. Because behavioral science is at the vanguard of open science practices, replications abound (there are thousands of them) to serve as ground truth training data. Key Hypothesis Therefore the pilot would test, in behavioral RCTs that have been replicated, whether the quality of evidence for a claim can be used to accurately predict whether that claim will replicate. Secondary Hypotheses Compared to claims that replicated, non-replicated claims demonstrate a greater share of forensic anomalies in their source literatures. Hypothesis level claim and statistic extraction is accurate enough to scale living evidence without onerous human review costs. Replication prediction is more accurate than prediction markets6 or journal prestige. If all the different quality signals we gather do accurately predict which studies will replicate, then we can use that model to score evidence to power the living evidence layer. Why this is informative regardless of outcome If the pilot succeeds, the architecture extends to medical RCTs (where Living Evidence already operates and integration is mostly about claim representation), then to slices of basic biology with stable replication structure. If it fails, the field learns which quality signals are load-bearing and which ones metascience has oversold. Either result is a contribution to knowing what the literature supports. Implications for funders Because this burgeoning ecosystem of builders already exists, a well-informed philanthropic or government funder could play a crucial catalyzing role in bringing this future about. They could play at least three roles: creating open structured datasets, publishing open benchmarks and incentivizing the solving of key technical challenges. First, open archives of papers that the government maintains, like PubMed, could be turned into structured data amenable to large scale metascience and claim aggregation. I know the US government already has an interest in doing this, though some key open questions remain unanswered. How do you determine the best models and systems for accurately extracting information from papers? How can you establish a robust way to allow researchers to flag errors and correct them? And finally, how do you create a legal regime in working with publishers to maximize the scope of available papers? For the latter, a university or a private philanthropy may be better positioned to make structured data publicly available under journal subscription terms or fair use. Philanthropists or government funders could also coordinate to create or commission benchmarks that evaluate whether important problems have been solved. For example, an open benchmark for claim extraction from a range of different scientific article types would be extremely helpful. Ensuring the underlying data are accurate is vital for creating these evaluations. I’ve discussed opportunistically using various human-created datasets for this purpose, but a consistent problem is that errors in human data make it difficult for them to serve as a gold standard. Finally, with structured data and benchmarks available, the government or private philanthropy could use them to incentivize groups to develop machine learning systems that meet these benchmarks. Prizes are one potentially valuable tool for this. For example, you could establish a prize for a system that accurately updates a living meta-analysis for a small set of claims. Prizes are particularly useful as signals of problem importance, and can help create vibrant ecosystems of public and private research—see, for example the role the government played in kickstarting the current work on nuclear fusion. Conclusion The drawbacks of the current scientific publishing system are known. Scientists agree, metascientists agree, philanthropists agree: the published PDF plus citation graph isn’t the right substrate for maintaining a representation of the evidence base in science. The pieces needed to build the alternative either already exist or are rapidly taking shape. The community is forming around exactly this problem, with concrete partnerships and shared infrastructure. A pilot should start on behavioral science RCTs because that’s the slice of empirical science most amenable to legibility, where replication ground truth is richest, and where the failure modes are best documented. What’s been missing is the galvanizing mission to assemble these pieces into something that works. That’s what I’m proposing to build. *** 1 I have a broader field map that I’ll release publicly soon. This is me, building in public! 2 If this is something that you are excited about, please reach out and talk to me. 3 More on this very soon too! 4 This tests whether, given the code and the data, you can get the same statistics as reported in the published paper. 5 This tests whether the results are the same as a paper’s given alternative analytical decisions in conducting the analysis (like outlier omission). Closely related is the idea of a “multiverse” where you come up with many different ways of answering the same underlying research question with the same data, and test whether the results hold in all those alternative methods. There’s been work on the latter as well. 6 Some of the replications, e.g. those from the SCORE project, had paired the experiments with forecasts from prediction markets. So we get to look at this for free.
Dr. Andrew Parsons: Dr. ChatGPT is getting remarkably good at diagnosing health problems — but actual doctors are still better at weighing treatment options
A father is worried about his toddler, who has been running a fever for two days and pulling at one ear. A 65-year-old woman has been getting winded on her morning walks and feeling more fatigued than usual. Both reach for their phones and type their symptoms into an AI
AI is getting remarkably good at diagnosing health issues, but doctors are still better at weighing treatment options
Knowing what ails a patient is necessary but not sufficient for determining how to care for them. And how to manage a patient is a complex question.
Rockies' Zach Agnos: Takes loss Saturday
Rockies' Zach Agnos: Takes loss Saturday
New study casts doubt on reliability of mental health diagnosis interviews
Diagnostic interviews seen as ‘gold standard’ vary in reliability from condition to condition, study says
Yankees to call up top prospect following Aaron Judge injury
The New York Yankees are turning to one of the organization’s most exciting young talents following the devastating injury news surrounding Aaron Judge. With Judge heading to the injured list after being diagnosed with a fractured rib, the Yankees have…
State health officials investigate possible cancer cluster at Uxbridge High School
Massachusetts health officials are investigating a possible cancer cluster at Uxbridge High School after several teachers were diagnosed with breast cancer.
WA doctors were sent for mental health help. It hurt their careers
Two former UW Medicine residents allege in a recent lawsuit that a physicians health program misdiagnosed them and threw their careers off track.
Opinion | Melinda French Gates: America Needs a Menopause Revolution
Too many women walk out of their doctors’ office with no diagnosis, no treatment and no plan.
Private equity firm acquires Heritage Imaging
ACP Partners is buying the Boise, Idaho-based mobile diagnostic imaging provider for an undisclosed sum, planning to pursue further add-on deals.
Teddi Mellencamp reveals emotional health update on cancer battle
Teddi Mellencamp was diagnosed with stage 4 melanoma in 2022, and by 2025, the cancer had metastasized to her lungs and brain.
Study finds link between neighborhood opportunity and mental health-related hospitalizations in youths
The study, published in the journal Psychiatric Services, is the first to examine relationships between neighborhood opportunity and specific mental health-related diagnoses and hospitalizations at a population level.
Several female teachers at Uxbridge High School diagnosed with breast cancer in recent years
Specialists are also reviewing the cases to “assess the statistical likelihood of common causes,” officials said.
International medical graduates represent nearly 25% of diagnostic radiologists in US
Recently policy changes under the Trump administration "highlight potential vulnerability in relying on this as a supply of radiologists," experts write in Academic Radiology.
Red Sox's Garrett Crochet: Diagnosed with low-grade strain
Red Sox's Garrett Crochet: Diagnosed with low-grade strain
Tuberculosis test may improve diagnosis
Researchers found that a new portable diagnostic test for tuberculosis produced rapid and accurate results.
Trump taps Bill Pulte as acting national intelligence director
He replaces Tulsi Gabbard, who resigned last month after revealing her husband's cancer diagnosis
Christopher Gasper, Boston Globe columnist and sports radio host, shares prostate cancer diagnosis
Boston sports media personality Christopher Gasper said he is preparing to undergo surgery for prostate cancer.
Everyday task may help detect early dementia signs before diagnosis, study finds
Scientists have discovered that a simple writing test could detect cognitive impairment in older adults before more serious symptoms develop.
Kevin Keegan confirms stage four cancer diagnosis as England legend issues health update
Kevin Keegan publicly shared details of his stage four cancer diagnosis during an appearance in Newcastle, as the Magpies sent their heartfelt support to their former manager
Kevin Keegan reveals stage four cancer diagnosis
Former England and Newcastle manager Kevin Keegan has revealed he has stage four cancer.Keegan twice took charge of Newcastle during his coaching career, also managing Fulham, Manchester City and England.
Jill Biden Defends Backing 2nd Term for Joe Biden: ‘Had to Be His Decision’
The former first lady also gave an update on the health of the 83-year-old former president after his prostate cancer diagnosis.
Life Sciences Investment Opportunities Accelerate as AI and Genomics Drive $200+ Billion Market Expansion
“Covering more than 25 recently published reports, the review provides a consolidated view of growth opportunities across healthcare technologies, biologics, diagnostics and therapeutic markets.”Boston, June 01, 2026 (GLOBE NEWSWIRE) -- The global life sciences industry is experiencing unprecedented growth momentum across multiple therapeutic and diagnostic segments, with cumulative market opportunities exceeding $200 billion by 2030, according to BCC Research's latest comprehensive analysis. Th
Veterans face surprising threat after cancer diagnosis, study reveals
A new JAMA Oncology study finds veterans with cancer face elevated suicide risk that can persist for up to five years following their diagnosis.
Women hope renaming PCOS health condition could help millions of women worldwide
Rochelle Lewis is among more than 170 million woman globally to be diagnosed with PCOS.
Madison market spotlights artists with mental health diagnoses
MADISON, Wis. — For the fourth consecutive year, a local craft market sent a powerful message: you are not alone.
Hopes £25m health hub will bring trade boost to Plymouth traders
The Community Diagnostics Centre in Plymouth's West End is due to open on 23 June.
Closing the diagnostics gap key to improving women's health
We must redesign women's health systems around early detection and integrated care, and recognize diagnostics as being foundational to effective care.
Dangerous diagnoses turn heart patient into a heart health advocate
14-year fight to save his failing heart has meant a world of change for James Young II, who now works to help others save their hearts too.
The healthcare creator is finally diagnosing how they best fit into the creator economy
Healthcare creators are powerful brand partners, but they have to fit into the creator economy without sacrificing their credibility
NYC Health + Hospitals to Open Second Bridge to Home Facility in Brooklyn to Expand Transitional Housing Program for Unhoused New Yorkers Diagnosed with Serious Mental Illness - NYC Health + Hospitals
New York, NY – NYC Health + Hospitals today announced that it will expand the Bridge to Home program to Brooklyn, building on the success of the program's
In Good Health: Chronic Pelvic Pain In Women
Chronic pelvic and vulvovaginal pain is surprisingly common among women of all ages. In fact, 1 in 3 women will experience a pelvic floor disorder at some point in their lifetimes.So, why is it so difficult to receive diagnosis and treatment for these conditions? And why don’t we talk about our pain ‘down there’ in general?In this installment in our series, “In Good Health,” we sit down with a panel of experts to talk about it.Find more of our programs online. Listen to 1A sponsor-free by signing up for 1A+ at plus.npr.org/the1a.
Inside Bruce Willis’ Health Journey: What to Know About the Actor’s Frontotemporal Dementia
Bruce Willis has been diagnosed with frontotemporal dementia, prompting his retirement from acting. Here’s everything to know about Bruce Willis’ health journey since his diagnosis.
Ebola, chemical plants and health, hantavirus, common colds, heat and more
As they say, bugs have ears. Public health has had a relentless May. Chemical plant (near) explosions, Ebola, hantavirus, and that's before you even get to the usual suspects: common colds, heat, and ticks. Here’s an attempt to keep you up to speed and, more importantly, what it means for you and your community. But first, an announcement: World Cup The World Cup starts in 15 days (not like anyone is counting down), and we are hanging TVs in the Health Security Operations Center. It’s going to be a gorgeous, chaotic celebration of basically every culture on earth. And it’s going to take a team effort—from communities to individuals, from public health to health care—to keep people healthy. That’s where you come in. If you’re going to the games or live within 30 miles of a stadium, we would love to hear from you. Sign up for a weekly survey here. Thanks to the more than 1,280 people who have already signed up…you will be hearing from us soon!! Global disease “weather report” Hantavirus: Two more cases The global count of cruise ship passengers with hantavirus has now increased to 13 cases (11 confirmed), with three deaths. The two new cases are overseas and among people who were already quarantining: A crew member in the Netherlands. A Spanish national passenger who was quarantining at home tested positive through daily monitoring. They are now in a biocontainment unit. In the U.S., everyone remains negative. There may be more cases, given that the incubation period of hantavirus (the time from exposure to infection) is 45 days. But this week, we will reach a major milestone: the median incubation window is 18 days, and that will pass on May 29. What this means for you: Your risk from this cruise ship outbreak remains essentially nil at this point. Ebola rages on in Central Africa Big thanks to Dr. Craig Spencer, a humanitarian physician who has treated and survived Ebola, for jumping in to provide the YLE community with an update. Craig, take it from here… The combined confirmed and suspected Ebola cases in DRC are now more than 1,000. All signs are pointing to a very long and catastrophic outbreak in Central Africa: This is a vast undercount. We know this because the test positivity rate is hovering around 50%, only 20% of contacts are being traced (and in some areas, no contacts at all), and more cases keep popping up with no known connection. This all points to widespread and undetected community transmission. This is in only a week of detection. Compared to previous outbreaks, the growth is very fast, as the huge West Africa outbreak in 2016 was first detected at 49 cases and rose to 208 cases a month later. It took four months for that outbreak to reach the size of the current one in the DR Congo. The cases are spread out across 16 health zones. There are now multiple epicenters, making containment very difficult. Next door in Uganda, the case count is seven. While this number is low compared to DRC, a concerning development is that two health care workers recently tested positive with uncertain exposure histories. If they weren’t treating known Ebola cases, this means it’s spreading undetected in Uganda as well. On the ground, backlash, including the burning of health centers, has emerged, a pattern seen in nearly every outbreak and rooted in deep community distrust. It often stems from outside actors working in communities without fully understanding or addressing local priorities. Affected populations may recognize the severity of Ebola while still holding other concerns as more pressing, such as where their loved ones are buried. Community trust is essential to an effective response, but difficult to build during an active emergency. It is best established long before a crisis begins. U.S. priorities are made clear, and may backfire. The U.S. Administration has shown that its first priority is keeping Ebola out, with helping end the outbreak in the DRC a secondary concern. That's meant travel restrictions broader than anything we've imposed before — covering travelers from across the region, and reportedly some green card holders and permanent residents as well. For example, just these past two days, news broke that high-risk American travelers will be subject to a mandatory quarantine in Kenya before they are allowed to return. If an American is infected, the U.S. government plans to send them to a hospital it is standing up from scratch in Kenya. (Currently, Americans who were in the area are allowed to return but are diverted to three airports—Houston, Atlanta, and DC—for further screening.) Past administrations have used travel notices and stepped-up screening; this goes much further. At first blush, these strict precautions may sound prudent. But this approach could backfire in three ways: Restrictions this blunt give people every reason to hide where they’ve been and whom they’ve been near — making the people we most need to find harder to track, not easier. They also breed a false sense that this is someone else’s problem. But diseases are humbling. They find the small cracks in even the most impenetrable-seeming defenses. Lives lost. There is no treatment for this Ebola strain, which means survival depends heavily on the quality of the health system. We have that system in the States, but we are choosing not to use it for infected Americans. This is unbelievable and infuriating. (See a deeper dive from me here.) The only real way to lower the risk to Americans — and everyone else — is to end the outbreak in the DRC and across the region. What this means for you: If you have travel plans to this region, it’s time to cancel them. This is a high-risk situation in Central Africa, and CDC released a Level 4 Travel Advisory. There is also great uncertainty if and when the Administration will let you back in. To the general public in the U.S., your risk remains very, very low right now. U.S. disease “weather report” Ticks: past peak season? Good news, especially for people in the Northeast and Midwest: tick numbers continue to decline. Though we are at the peak of the season, this unusually early year is trending favorably. Heat-related illnesses in the North Heat risk is certainly not blanketing the entire country yet, but this week it will be moderate in the Midwest and the Southeast. What this means for you: Be sure to check the CDC HeatRisk tool. A red day isn’t the best day for that soccer game for a kid with asthma, and a stretch of orange days is a great time to check on your elderly neighbor. Common colds surging As far as respiratory viruses go, the only thing really going around right now is the common cold. It is higher this year than last year, but should peak very soon before returning this fall. Spotlight: Chemical plants Over the weekend, YLE California covered the serious situation that unfolded around a chemical plant in Orange County, California. Thankfully, the worst-case scenario (a chemical explosion) was mitigated, but only through luck. The health implications in a densely populated area could have been catastrophic. As the situation was winding down, another chemical explosion struck Washington State. This one was fatal. Health officials say the risk to surrounding residents from chemicals in the air and ground remains low, though the community deserves far greater clarity. Clean air and clean water consistently rank as Americans’ top public health concerns — yet when chemical disasters strike, communities are too often met with reassurances rather than transparency and accountability. Residents near the 2023 East Palestine, Ohio train derailment, for example, are still waiting to understand the long-term impact on their health, with few clear answers. What this means for you: Many are wondering if facilities processing potentially dangerous materials are in their neighborhoods. This interactive map allows you to enter your ZIP code and see all facilities monitored by the EPA, including any violations. Good news Ebola vaccines and treatment for the Bundibugyo species are in development. Two vaccine platforms are being explored, at least one of which may be deployable in as little as 2 months. One vaccine is being developed by Oxford, and the other uses the same biotechnology as the FDA-approved Zaire species of Ebola. (It may provide cross-protection, but it’s unclear at this point.) On the treatment side, two promising monoclonal antibody cocktails are likely to be deployed, though doses are limited and logistical hurdles remain significant challenges. Anni over at The Biotech Tea had a great explainer about the Ebola vaccine gap, if you want to read more. [ The Biotech Tea The Ebola vaccine gap, reading vessel damage, & the Makary exit 🗝️ Paid subscribers get the Biotech Term of the Week at $30/year (~$2.50/month). I try to keep it intentionally accessible, but if cost is ever a barrier, send me a message. A few people asked about expensing your subscription, so I put together a short email template… Read more 6 days ago · 10 likes · Annicka Evans, PhD ](https://www.thebiotechtea.com/p/the-ebola-vaccine-gap-reading-vessel?utm_source=substack&utm_campaign=post_embed&utm_medium=web) Polycystic ovary syndrome (PCOS) has been officially renamed polyendocrine metabolic ovarian syndrome (PMOS), following more than a decade of debate and input from roughly 22,000 clinicians, researchers, and patients worldwide. This is good because the old name was medically misleading, leading to patients without visible cysts being dismissed or overlooked entirely. The WHO estimates that 70% of people with the condition remain undiagnosed. A more accurate name should improve recognition, reduce stigma, and ultimately help the millions of people living with this condition get diagnosed and treated sooner. Poll Loading... Bottom line Public health situations are everywhere right now. Staying healthy takes public health professionals and systems working tirelessly behind the scenes and each of us showing up for our neighbors and communities. Love, YLE Big thanks to Ed Nirenberg for staying on top of the Ebola vaccines, Hannah Totte for all the figures, Dr. Craig Spencer for the Ebola insight, and Dr. Matt Willis for covering the chemical situation in CA. Your Local Epidemiologist (YLE) comprises a team of experts, ranging from physicians to immunologists to epidemiologists to nutritionists, working together with one goal: to “Translate” ever-evolving public health science so that people are well-equipped to make evidence-based decisions. YLE suite of newsletters reaches over 475,000 people across more than 132 countries. This newsletter is free to everyone, thanks to the generous support of fellow YLE community members. To support the effort, subscribe or upgrade below: Subscribe
Argentina coach Scaloni encouraged by news on Messi injury
Argentina coach Lionel Scaloni said the initial news regarding superstar Lionel Messi's fitness "is not that bad" and hopes further examinations will confirm that diagnosis with the World Cup just a fortnight away."Now one has to wait and see how it evolves and above all the new tests they are going to conduct in order to see if it confirms their original diagnosis."
FinTech Pet Care Software Kennel Connection Brings Petwealth Pet Health Diagnostics to Pet Boarding & Daycare Expo West Following Strong Industry Reception at Intergroom
MOORPARK, Calif., May 26, 2026--Kennel Connection expands its exclusive Petwealth diagnostics partnership to Pet Boarding & Daycare Expo West following strong reception at Intergroom
Girls with ADHD from deprived backgrounds may face a higher risk of long-term health conditions
Girls from a deprived background who are diagnosed with attention deficit hyperactivity disorder (ADHD) may be more likely to experience multiple long-term health conditions, or multimorbidity, in adulthood, ...
Aspira Women’s Health and Cleveland Clinic Expand Strategic Collaboration to Advance AI-Powered Diagnostics in Women’s Health
Collaboration aims to accelerate biomarker discovery, strengthen translational research capabilities, and support scalable clinical validation
BioTools Innovator 2026 Cohort Includes Top 30 Life Science Tools and Diagnostics Companies
BioTools Innovator selected 30 life science startups for its 2026 Accelerator, with companies competing for $300K in funding.
What To Expect After a Myositis Diagnosis
When you’re diagnosed with myositis, it can be a relief to finally know what’s behind your symptoms. But then what? Here’s what to expect.
Jardine to Buy Australian Imaging Firm I-MED in $2.4 Bilion Deal
Jardine Matheson Holdings Ltd. agreed to buy Australian medical diagnostic imaging provider I-MED Radiology Network Ltd. from private equity firm Permira, as the Asia-focused conglomerate seeks to expand its portfolio.
'We can identify these really early, before the clinical diagnosis': Epigenetic markers may help explain why Native Hawaiians are aging faster
Live Science spoke with Alika Maunakea, an Native Hawaiian epigeneticist, about how epigenetics underpins health disparities between Native Hawaiians and others in Hawaii.
Mental health, anxiety visits more common at Mass. pediatrician's offices
Visits for anxiety grew more than any other prominent mental health diagnosis.
Media, Democrats suggest politics behind Tulsi Gabbard's exit amid husband's cancer battle
The Daily Signal national correspondent Tony Kinnett discusses the response to Tulsi Gabbard's resignation due to her husband's diagnosis with a rare form of bone cancer.
Donald Trump Jr.’s Inner Circle Rallying Around Ex- Vanessa Amid Health Struggle
Donald Trump Jr.’s ex-wife, Vanessa Trump, is reportedly being surrounded by support from both her family and the wider Trump circle following her breast cancer diagnosis. Insiders close to the family...
Steam Controller Gets HID Remapper Support for 3rd-Party Compatibility
HID Remapper is an open-source, hardware-agnostic project that makes input devices remappable with a hardware USB adaptor that sits between the input device and the host device and converts inputs from the controller into a signal that is compatible with the host. According to a new May 20 update to...
Legionnaires' disease concerns at East Village housing complex prompts NYC Health Department response
New York City's Department of Health has launched an evaluation of East Village apartment complex after two residents were diagnosed with Legionnaires' disease over the course of a year.
Tulsi Gabbard Resigns as Trump’s Intelligence Chief
In her resignation letter, Gabbard says she is leaving her post as director of National Intelligence following her husband’s cancer diagnosis.
EXCLUSIVE: Tulsi Gabbard resigns from Trump Cabinet
Tulsi Gabbard notified President Trump she is resigning as DNI, citing her husband Abraham's diagnosis with an extremely rare form of bone cancer.
World Health Assembly endorses resolution on precision medicine
At the Seventy-ninth World Health Assembly, Member States endorsed a new resolution on Precision medicine: a path towards targeted, personalized and equitable care, taking an important step towards advancing precision medicine as part of efforts to strengthen equitable, effective and sustainable health systems. Precision medicine refers to the use of clinical, molecular, genomic and other health data to inform prevention, diagnosis and treatment, taking into account variability while applying appropriate ethical and legal safeguards. When integrated responsibly into health systems, precision approaches can improve outcomes across different disease areas and across the life course – from cancer and rare diseases to infectious diseases, maternal, newborn and child health, mental health and noncommunicable diseases. The resolution reflects rapid advances in genomics, diagnostics, data science and digital health, alongside widening global inequities in access to these innovations. Many populations – particularly in low- and middle-income countries – remain underrepresented in data and research, limiting the public health impact of precision medicine and risking the widening of health disparities if action is not taken now. "Precision medicine is not an aspirational idea for health delivery in the future – it is already transforming lives across the world. But its benefits remain out of reach for too many and the research driving progress is concentrated in high income countries. This WHA resolution gives global health leaders, ministries of health, and WHO a clear mandate: to act. From infant screening to setting up genomic databases WHO will work with countries to bring about the power of these innovations." Dr Meg Doherty, Director Science for HealthThrough the resolution, Member States commit to developing and strengthening national policies, infrastructure, workforce capacity and governance frameworks to support the safe, ethical and equitable integration of precision medicine into health systems, aligned with universal health coverage. This includes promoting affordability, ensuring inclusive research and data systems, strengthening regulation and data governance, and fostering collaboration across sectors and regions.WHO is requested to provide technical and normative support, review and coordinate existing guidance, facilitate global and regional collaboration, and develop a Global Strategy on Precision Medicine to guide equitable and context‑appropriate implementation. WHO stands ready to support Member States through tools such as a country maturity model for countries to self-assess capacity in implementing precision medicine depending on their context. In the immediate term WHO will map all existing guidance and frameworks and host extensive consultations with interest holders globally.By placing equity, inclusion and public value at the centre of precision medicine, the resolution reinforces WHO’s commitment to ensuring that scientific advances benefit all people, everywhere, and that no one is left behind in the next era of health innovation."By uniting people-centered healthcare with innovation, precision medicine has the potential to transform lives. This resolution helps ensure those advances serve the shared goal of health for all." Dr Sylvie Briand, Chief Scientist For further information please visit the Health Topic: Genomics
Diamondbacks 2, Rockies 1: Duel of the Fates
Zach Agnos shines on the mound as the Rox drop the series opener
Could the secret to diagnosing endometriosis be hiding in plain sight?
Although menstrual blood is typically discarded, researchers are beginning to use it to reveal new clues about women’s health.
Nearly 60% of college students with a psychosis diagnosis are not receiving the recommended mental health treatment
Despite a low overall prevalence of psychosis in the United States, affecting three percent of the population, this condition is a serious public health concern because people often delay seeking care ...
Why renaming this common hormonal disorder is a huge deal
You probably know someone who has a condition that, until last week, was known as PCOS, or polycystic ovary syndrome. It affects one in eight reproductive-aged women. But despite it being such a common disorder, patients are often misdiagnosed and have delayed treatment. Now, medical professionals are trying to change that. After 15 years of work, the condition has been renamed to PMOS, or polyendocrine metabolic ovarian syndrome. The new name reflects the real driver of the condition: disruptions in hormones. But how much can changing a name really do? Click here to access resources about PMOS in multiple languages. Interested in more science? Email us your question at shortwave@npr.org.Listen to every episode of Short Wave sponsor-free and support our work at NPR by signing up for Short Wave+ at plus.npr.org/shortwave.
Primary Care Making More Mental Health Diagnoses for Kids
Pediatric mental health visits in primary care surged over a 9-year period.
Texas health officials report first human West Nile case of the year
A Texas resident has been diagnosed with West Nile neuroinvasive disease, a severe and relatively rare complication of the illness. It’s the first reported human case of West Nile in Texas this...
Barcelona Institute for Global Health: Expanded TB screening does not speed up treatment initiation or improve survival in hospitalised patients with HIV
Adding molecular tests on sputum, urine and stool samples does not appear to outperform the standard WHO-recommended diagnostic approach.
A hidden barrier to starting a family
Endometriosis is a widespread disease affecting at least one in eight women, often leading to infertility, which can be prevented with earlier diagnosis and treatment.
Innovation Developed by UT Health Sciences Research Program Passes Landmark Trial for Cardiac Amyloidosis
A new diagnostic tool developed at the University of Tennessee Health Sciences may soon make it significantly easier for physicians to detect cardiac amyloidosis, a progressive and frequently underdiagnosed disease caused by abnormal protein deposits in the heart.
Reimagining mental health: Stanford Medicine experts chosen to lead precision task force
Stanford Medicine’s Leanne Williams was chosen to lead the Precision Mental Health Commission to redefine and streamline how psychiatric conditions are diagnosed and treated. She’s pushing for a data-driven approach that begins with brain imaging.
Elliott builds big stake in life-science tools supplier Bio-Rad Labs, WSJ reports
Activist investor Elliott Investment Management has built a sizeable stake in U.S. diagnostics supplier Bio-Rad Laboratories NYSE:BIO, and plans to push the company to boost its underperforming stock price, the Wall Street Journal reported on Sunday.Bio-Rad's shares have fallen more than 18% so fa…
Open-Source "low_latency_layer" Brings Reflex & Anti-Lag 2 To AMD & Intel GPUs On Linux
A new open-source project called low_latency_layer is an implicit Vulkan layer that enables AMD Anti-Lag 2 and NVIDIA Reflex 2 to reportedly work in a hardware-agnostic manner so that AMD and Intel graphics cards can both enjoy Reflex or Anti-Lag 2 working on non-AMD graphics cards as well.
LSU LCMC Health Cancer Center reshapes healthcare with clinical trials that are at the forefront of medical innovation
For Denise Phipps, a frightening trip to the emergency room for chest pain turned into a diagnosis that could have easily stripped away hope.